Navigation Links
Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
Date:9/12/2007

EXTON, Pa., Sept. 12 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its first quarter ended September 30, 2007 at 7:00 A.M. Eastern Time on Friday, October 19, 2007.

Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Friday, October 19, 2007 at 9:00 A.M. Eastern Time.

To participate in the teleconference call, dial 1-651-291-5254. The teleconference call will also be available for replay starting Friday, October 19, 2007 at 12:30 P.M. Eastern Time through Friday, October 26, 2007 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 886702.

Individuals interested in listening to the teleconference may also do so over the Internet at http://www.kenseynash.com. To listen to the live teleconference call, please go to the http://www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the http://www.kenseynash.com website and may be accessed following the teleconference.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 2016 , ... According to the Webster’s dictionary, a hippie is defined as ... one company is going against the norm with a line of all-natural skincare that’s ... the green space is proud to announce its latest retail partnership with the Vitamin ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... weekend to host their second pop-up shop for three consecutive weekends. The pop-up ... to the Santa Barbara community, a community full of women who appreciate the ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... been hired as FluidEdge’s Vice President of Business Intelligence and Informatics, effective immediately. ... has demonstrated success leading teams as a healthcare business and financial strategist for ...
(Date:5/25/2016)... ... ... The United States Food and Drug Administration (FDA) has now cleared Capillus® laser ... the company is the first and only manufacturer of low level laser therapy (LLLT) ... , “This new level of clearance substantiates what many physicians have experienced firsthand ...
(Date:5/25/2016)... Pembroke Pines, FL (PRWEB) , ... ... ... Hospital West has received the American Heart Association/American Stroke Association's Get With ... Plus designation. , This achievement, a second for Memorial Healthcare System, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... HILDEN , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... into a licensing and co-development agreement with Therawis Diagnostics GmbH ... project will be to develop and market PITX2 as a ... and other high-risk breast cancer patients. "We are ...
(Date:5/25/2016)... YORK , May 25, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... Syringe, Insulin Pump and Others)" published by P&S Market ... at $9,998.3 million in 2015, and it is expected ... Based on type, the insulin pump segment is expected ...
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
Breaking Medicine Technology: